STIM

Neuronetics, Inc.

2.03 USD

Last updated Dec 6, 00:52 UTC

Yesterday HIGH

$2.25

Yesterday LOW

$2

52w HIGH

$6.95

52w LOW

$1.03

EPS

-0.33

PE

-6.15

Next Earnings

Mar 5, 2024

Overview News Government Trades

Neuronetics, Inc. stock is up 56.15% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 5 December’s closed higher than November.

Neuronetics, Inc. offers non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

neurostar.com

bharat@benzinga.com

Tue Aug 8, 2023

Neuronetics Q2 EPS $(0.17) Beats $(0.35) Estimate, Sales $17.61M Beat $17.38M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.35) by 51.43 percent. This is a 56.41 percent increase over losses of $(0.39) per share from the
Benzinga Insights

Tue Aug 8, 2023

Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
Benzinga Insights

Mon Aug 7, 2023

Stocks That Hit 52-Week Lows On Monday

On Monday, 149 companies reached new 52-week lows.
Benzinga Insights

Fri Aug 4, 2023

Stocks That Hit 52-Week Lows On Friday

On Friday, 73 companies reached new 52-week lows.
Nabaparna Bhattacharya

Mon Jul 17, 2023

Neuronetics' NeuroStar Gets Regulatory Clearance In South Korea

Neuronetics, Inc. (NASDAQ: STIM) announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved multiple features of NeuroStar TMS (transcranial magnetic stimulation) for
Happy Mohamed

Mon Jul 17, 2023

NeuroStar Achieves Milestone Regulatory Clearance In South Korea

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced
Benzinga Newsdesk

Mon Jun 12, 2023

Neuronetics Receives 510(k) Clearance For Obsessive-Compulsive Disorder Motor Threshold Cap For Neurostar Advanced Therapy
Happy Mohamed

Fri May 26, 2023

Neuronetics Announces Increased Transcranial Magnetic Stimulation Access Through BlueCross BlueShield Of Michigan

Neuronetics, Inc.
Benzinga Newsdesk

Wed May 10, 2023

JMP Securities Reiterates Market Outperform on Neuronetics, Maintains $12 Price Target

JMP Securities analyst David Turkaly reiterates Neuronetics (NASDAQ:STIM) with a Market Outperform and maintains $12 price target.
Lisa Levin

Tue May 9, 2023

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.